Regulatory Strategy Consultation for SaMD
Achieving rapid and compliant market access for Software as a Medical Device (SaMD) requires a well defined, region specific regulatory strategy. As digital health expands with AI driven diagnostics, continuous monitoring technologies, and mobile health platforms, regulatory expectations have become increasingly intricate. Masuu Global Solutions simplifies this complexity, creating a clear pathway for global compliance.
Overview
At Masuu Global Solutions, we help organizations navigate the full spectrum of SaMD regulatory requirements. Our expert teams deliver end to end compliance support, addressing major international standards including IEC 62304, ISO 13485, ISO 14971, and EU MDR/IVDR expectations.
We streamline approvals across key markets such as the United States and European Union, offering hands on guidance for FDA 510(k) pathways and CE marking processes. By aligning your software design, documentation, risk management, and clinical evidence with regional requirements, we accelerate your global launch while reducing regulatory risk.
With deep experience in regulatory strategy, gap assessment, technical documentation, and risk controls, Masuu Global Solutions serves as your partner through every stage of SaMD commercialization—from classification to global market harmonization.
Regulatory Strategy Consultation Services
Our Services Include:
- Comprehensive evaluation of your SaMD’s purpose, functionality, and market goals
- Detailed review of technical documentation with gap identification
- Country specific risk classification based on regional frameworks
- Mapping of relevant global standards (ISO 13485, IEC 62304, IEC 82304 1, etc.)
- Identification of suitable regulatory pathways such as 510(k), CE marking, MDL, Shonin/Ninsho, and others
Every output is customized to the product, region, and commercialization timeline.
Regulatory Pathways & In Country Representation
- United States (FDA): SaMD qualification, 510(k), De Novo, and PMA submissions
- European Union (EU MDR): Classification of Medical Device Software (MDSW), CE marking for Classes I–III
- Japan (PMDA): Ninsho and Shonin pathways for Class II/III SaMD
- Global Markets: Support for APAC, LATAM, Middle East, and additional regions
Where required, Masuu also serves as your local regulatory representative, ensuring seamless communication with authorities and maintaining regional compliance.
Regulatory Intelligence & Roadmap Development
Our Services Include:
- Ongoing updates on changes in FDA guidance, MDCG publications, PMDA revisions, MFDS updates, etc.
- Horizon scanning for emerging AI/ML related regulatory trends
- Competitor pathway analysis and benchmarking
- Creation of detailed regulatory roadmaps aligned with your launch plans
Our strategic roadmaps outline key milestones across pre submission, documentation, submission, and post approval phases—helping you plan budgets, predict timelines, and manage risks.
Global Strategy & Market Expansion
Our Cross Market Services Include:
- Comparative regulatory mapping across more than 10 global regions
- Document reuse and adaptation strategy
- Input from cybersecurity, clinical, and QMS specialists
- Tailored support for synchronized multi market submissions
As digital health becomes globally interconnected, scalable regulatory planning becomes essential to growth. Masuu ensures your SaMD is built for expansion.
Challenges vs. Your Benefits with Masuu’s SaMD Solutions
Complex & Evolving Regulations
Regulations such as FDA QSR, EU MDR, ISO 13485, ISO 14971, IEC 62304, and privacy laws can delay development without a structured QMS.
- Fast, audit ready compliance
- Immediate access to ISO aligned QMS frameworks
High Costs & Fragmented Efforts
Coordinating expertise across Notified Bodies, consultants, and authorities increases costs and creates inefficiencies.
- Full QARA team at a predictable monthly cost
- Over 50% cost savings vs. building in house teams
- Full regulatory coverage at less than the cost of one internal FTE
Long & Risk Prone Timelines
QMS setup, CE approvals, and FDA submissions often stretch into months or years.
- Cut 6+ months from QMS and ISO certification timelines
- Avoid rework through expert led documentation
- Save €50K+ on QMS and eQMS implementation
- Proven success rate across global SaMD registrations